Absolutely! I have posted here before that I think seasonal allergies ought to be the VERY FIRST disease RCPI targets. Anatabloc is absolutely better than any other allergy medication that I have used.
The FDA studies for an allergy medication should be quick and inexpensive. Also, once it is approved for allergies, it should be easier to get it approved for other indications. Additionally, most of us who already use Anatabloc should be able to convince our Doctors to prescribe Anatabloc as our preferred allergy med, thus giving us access once again to a dependable supply of Anatabloc.
And RCPI would once again have a source of revenue...
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.